Lista de obras -

Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity

scientific article published on 23 December 2020

Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway ⬇️

artículo científico publicado el 6 de julio de 1993

Comparison of analytical methods to detect instability of etanercept during thermal stress testing ⬇️

artículo científico publicado el 24 de enero de 2011

Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis

artículo científico publicado en 2015

Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and anti-adalimumab in patients with inflammatory diseases

artículo científico publicado en 2017

Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay

scientific article published on 01 January 2019

Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.

artículo científico publicado en 2015

Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis.

artículo científico publicado en 2015

Immunogenicity of biologic therapies—we need tolerance ⬇️

artículo científico publicado el 1 de octubre de 2010

Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies

artículo científico publicado en 2017

Interleukin-1 Blockade Attenuates Mediator Release and Dysregulation of the Hemostatic Mechanism During Human Sepsis ⬇️

artículo científico publicado el 1 de julio de 1995

Optimal concentration range of golimumab in patients with axial spondyloarthritis

artículo científico publicado en 2017

Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects

artículo científico publicado en 2013

Progression of structural damage is not related to rituximab serum levels in rheumatoid arthritis patients

artículo científico publicado en 2013

Response to: Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial' by den Broeder et al.

artículo científico publicado en 2017

Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort study

artículo científico publicado en 2016

Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study ⬇️

artículo científico publicado el 27 de diciembre de 2010

The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review ⬇️

artículo científico publicado el 20 de octubre de 2010

The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia ⬇️

artículo científico publicado el 9 de noviembre de 2010

Venous and arterial thromboembolic events in adalimumab‐treated patients with antiadalimumab antibodies: A case series and cohort study ⬇️

artículo científico publicado el 1 de abril de 2011

Lista de obras de

Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity

Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway ⬇️

Comparison of analytical methods to detect instability of etanercept during thermal stress testing ⬇️

Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis

Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and anti-adalimumab in patients with inflammatory diseases

Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay

Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.

Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis.

Immunogenicity of biologic therapies—we need tolerance ⬇️

Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies

Interleukin-1 Blockade Attenuates Mediator Release and Dysregulation of the Hemostatic Mechanism During Human Sepsis ⬇️

Optimal concentration range of golimumab in patients with axial spondyloarthritis

Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects

Progression of structural damage is not related to rituximab serum levels in rheumatoid arthritis patients

Response to: Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial' by den Broeder et al.

Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort study

Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study ⬇️

The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review ⬇️

The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia ⬇️

Venous and arterial thromboembolic events in adalimumab‐treated patients with antiadalimumab antibodies: A case series and cohort study ⬇️